课题基金 / 基金详情

The specific SM molecular species that these endogenous SM species interacted with HCV nonstructural 5B polymerase to enhance viral replication

The specific SM molecular species that these endogenous SM species interacted with HCV nonstructural 5B polymerase to enhance viral replication
这些内源性 SM 种类与 HCV 非结构 5B 聚合酶相互作用以增强病毒复制的特定 SM 分子种类
批准号:
21390145
负责人:
KOHARA Michinori
金额:
$11.81万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

KOHARA Michinori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lipids are key components in the viral life cycle that affect host-pathogen interactions. In this study, we investigated the effect of HCV infection on sphingolipid metabolism, especially on endogenous SM levels, and the relationship between HCV replication and endogenous SM molecular species. We demonstrated that HCV induces the expression of the genes encoding sphingomyelin(SM) synthases. We observed associated increases of both total and individual sphingolipid molecular species, as assessed in human hepatocytes and in the detergent-resistant membrane(DRM) fraction in which HCV replicates. SGMS-1 expression had a strong correlation with HCV replication. Inhibition of sphingolipid biosynthesis with a hepatotropic serine palmitoyltransferase inhibitor, NA808, suppressed HCV-RNA production while also interfering with sphingolipid metabolism. Further, we identified the specific SM molecular species that comprise the DRM fraction and demonstrated that these endogenous SM species interacted with HCV nonstructural 5B polymerase to enhance viral replication. Our results reveal that HCV alters sphingolipid metabolism to promote viral replication, providing new insights into the formation of the HCV replication complex and the involvement of host lipids in the HCV life cycle.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An orally available, small-molecule interferon inhibits hepatitis C virus replication
口服小分子干扰素可抑制丙型肝炎病毒复制
DOI: --
发表时间: 2012
期刊: Sci. Comm
影响因子: --
作者: [Konoishi H., Okamoto K., Ohmori Y., Yoshino H., Ohmori H., Ashiara M., Hirata Y., Ohta A., Sakamoto H., Hada N., Katsume A., Kohara M., MOrikawa K., Tsukuda T., Shimma N., Foster G., Alazawi W., Aoki Y., Arisawa M., Sudoh M.]
通讯作者: Sudoh M.
Monoclonal antibody 2-152a suppresses hepatitis C virus infection thorough betaine/GABA transporter-1
单克隆抗体2-152a通过甜菜碱/GABA转运蛋白1抑制丙型肝炎病毒感染
DOI: --
发表时间: 2011
期刊: J. Infectious Disease
影响因子: --
作者: [Satoh M., Saito M., Takano T., Kasama Y., Nishimura T., Nishito Y., Hirata Y., Arai M., Sudoh M., Kai C., Kohara M., Tsukiyama-Kohara K.]
通讯作者: Tsukiyama-Kohara K.
Interferon-lambda plays a critical role in antiviral response in human hepatocytes
干扰素-lambda 在人肝细胞的抗病毒反应中发挥着关键作用
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [*Ebisuno, Y., * Katagiri, K., Katakai, T., Ueda, Y., Nemoto, T., Inada, H., Nabekura, J., Okada, T., Kannagi, R., Tanaka, T., Miyasaka, M., Hogg, N. & Kinashi, T, 石戸聡, Hirata Y.]
通讯作者: Hirata Y.
Suppression of sphingomyelin augmented by hepatitis C virus has robust anti-viral effects in human livers
丙型肝炎病毒增强的鞘磷脂抑制对人类肝脏具有强大的抗病毒作用
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Ohno, H., Hirata Y.]
通讯作者: Hirata Y.
104
    Pathology of spontaneous breast tumor in tree shrews (Tupaia belangeri chinenesis)
    Macrocycles to target influenza viral hemagglutinin as bifunctional potent broad-spectrum antiviral agent
    iHA-100 exhibited a high efficacy whether administered during the early phase or late phase of H5N1 infection
    Influenza viral hemagglutinin-targeted macrocyclic peptides as an antiviral agent
    海外基金